Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: MIDNIGHT SUN TECHNOLOGIES LLC
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2020-05-21 to 2021-05-31
Current total value of award: $1298400.16
Description: SCIENTIFIC SUPPORT FOR THE GENERIC DRUG PROGRAM FOR RESEARCH ACTIVITIES, WHICH SUPPORT THE DEVELOPMENT OF NEW METHODOLOGIES AND TOOLS FOR DEVELOPMENT AND DEMONSTRATION OF BIOEQUIVALENCE (BE).